{"transactions":[{"id":2531630,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-29T23:23:01.000Z","date":"2021-10-28","kind":"grant","acquired":true,"shares":37500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares underlying this option vest as follows: 25% of the shares vest on the first anniversary of October 28, 2022 with the remainder vesting thereafter in annual installments."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest as follows: 25% of the shares vest on the first anniversary of October 28, 2022 with the remainder vesting thereafter in annual installments."}],"balance_after":37500,"derivative":{"exercise_price":14,"expiration_date":"2031-10-27","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0000899243-21-042078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000089924321042078/doc4.xml","form_type":"4"}},{"id":2531629,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-10-29T23:23:01.000Z","date":"2021-10-28","kind":"grant","acquired":true,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit award under the Company's 2021 Stock Option and Incentive Plan. Each restricted stock unit represents the right to receive one share of the Company's common stock. These restricted stock units vest in four substantially equal annual installments beginning on the one year anniversary of the date of grant."}],"balance_after":8750,"source":{"system":"sec-edgar","filing":"0000899243-21-042078","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000089924321042078/doc4.xml","form_type":"4"}},{"id":2957816,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T22:17:14.000Z","date":"2020-12-01","kind":"exercise","acquired":false,"shares":58937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on January 20, 2018, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":16842,"derivative":{"exercise_price":10.39,"expiration_date":"2027-01-19","underlying":"Common Stock","underlying_shares":58937},"source":{"system":"sec-edgar","filing":"0001209191-20-061537","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120061537/doc4.xml","form_type":"4"}},{"id":2957815,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T22:17:14.000Z","date":"2020-12-01","kind":"exercise","acquired":false,"shares":78124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on January 24, 2019, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":46876,"derivative":{"exercise_price":10.45,"expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":78124},"source":{"system":"sec-edgar","filing":"0001209191-20-061537","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120061537/doc4.xml","form_type":"4"}},{"id":2957814,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2020-12-03T22:17:14.000Z","date":"2020-12-01","kind":"sale","acquired":false,"shares":58937,"price":17.35,"value":1022556.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":4523,"source":{"system":"sec-edgar","filing":"0001209191-20-061537","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120061537/doc4.xml","form_type":"4"}},{"id":2957813,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2020-12-03T22:17:14.000Z","date":"2020-12-01","kind":"exercise","acquired":true,"shares":58937,"price":10.39,"value":612355.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":63460,"source":{"system":"sec-edgar","filing":"0001209191-20-061537","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120061537/doc4.xml","form_type":"4"}},{"id":2957812,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2020-12-03T22:17:14.000Z","date":"2020-12-01","kind":"sale","acquired":false,"shares":78124,"price":17.66,"value":1379669.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":4523,"source":{"system":"sec-edgar","filing":"0001209191-20-061537","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120061537/doc4.xml","form_type":"4"}},{"id":2957811,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2020-12-03T22:17:14.000Z","date":"2020-12-01","kind":"exercise","acquired":true,"shares":78124,"price":10.45,"value":816395.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":82647,"source":{"system":"sec-edgar","filing":"0001209191-20-061537","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120061537/doc4.xml","form_type":"4"}},{"id":2992325,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2020-11-04T21:09:13.000Z","date":"2020-11-02","kind":"sale","acquired":false,"shares":772,"price":14.92,"value":11518.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 646 shares acquired by the reporting person under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on October 31, 2020."}],"balance_after":4523,"source":{"system":"sec-edgar","filing":"0001209191-20-056883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120056883/doc4.xml","form_type":"4"}},{"id":3006896,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-14T22:00:15.000Z","date":"2020-10-13","kind":"exercise","acquired":false,"shares":721,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on January 20, 2018, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":75779,"derivative":{"exercise_price":10.39,"expiration_date":"2027-01-19","underlying":"Common Stock","underlying_shares":721},"source":{"system":"sec-edgar","filing":"0001209191-20-054825","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120054825/doc4.xml","form_type":"4"}},{"id":3006895,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-14T22:00:15.000Z","date":"2020-10-13","kind":"exercise","acquired":false,"shares":38550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on February 15, 2020, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":64250,"derivative":{"exercise_price":9.21,"expiration_date":"2029-02-14","underlying":"Common Stock","underlying_shares":38550},"source":{"system":"sec-edgar","filing":"0001209191-20-054825","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120054825/doc4.xml","form_type":"4"}},{"id":3006894,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2020-10-14T22:00:15.000Z","date":"2020-10-13","kind":"sale","acquired":false,"shares":721,"price":17.2,"value":12401.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":4649,"source":{"system":"sec-edgar","filing":"0001209191-20-054825","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120054825/doc4.xml","form_type":"4"}},{"id":3006893,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2020-10-14T22:00:15.000Z","date":"2020-10-13","kind":"exercise","acquired":true,"shares":721,"price":10.39,"value":7491.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":5370,"source":{"system":"sec-edgar","filing":"0001209191-20-054825","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120054825/doc4.xml","form_type":"4"}},{"id":3006892,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2020-10-14T22:00:15.000Z","date":"2020-10-13","kind":"sale","acquired":false,"shares":38550,"price":16.85,"value":649567.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":4649,"source":{"system":"sec-edgar","filing":"0001209191-20-054825","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120054825/doc4.xml","form_type":"4"}},{"id":3006891,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2020-10-14T22:00:15.000Z","date":"2020-10-13","kind":"exercise","acquired":true,"shares":38550,"price":9.21,"value":355045.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":43199,"source":{"system":"sec-edgar","filing":"0001209191-20-054825","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120054825/doc4.xml","form_type":"4"}},{"id":3034105,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2020-09-10T12:49:22.000Z","date":"2020-09-08","kind":"exercise","acquired":false,"shares":10054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on January 15, 2017, and the remaining 75% vested in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":6.54,"expiration_date":"2026-01-14","underlying":"Common Stock","underlying_shares":10054},"source":{"system":"sec-edgar","filing":"0001209191-20-049920","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120049920/doc4.xml","form_type":"4"}},{"id":3034104,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2020-09-10T12:49:22.000Z","date":"2020-09-08","kind":"sale","acquired":false,"shares":10054,"price":14.98,"value":150608.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":4649,"source":{"system":"sec-edgar","filing":"0001209191-20-049920","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120049920/doc4.xml","form_type":"4"}},{"id":3034103,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2020-09-10T12:49:22.000Z","date":"2020-09-08","kind":"exercise","acquired":true,"shares":10054,"price":6.54,"value":65753.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":14703,"source":{"system":"sec-edgar","filing":"0001209191-20-049920","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120049920/doc4.xml","form_type":"4"}},{"id":3154178,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2020-05-11T20:25:07.000Z","date":"2020-05-07","kind":"exercise","acquired":false,"shares":2946,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on January 15, 2017, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":10054,"derivative":{"exercise_price":6.54,"expiration_date":"2026-01-14","underlying":"Common Stock","underlying_shares":2946},"source":{"system":"sec-edgar","filing":"0001209191-20-028268","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120028268/doc4.xml","form_type":"4"}},{"id":3154177,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2020-05-11T20:25:07.000Z","date":"2020-05-07","kind":"sale","acquired":false,"shares":2946,"price":20,"value":58920.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":4649,"source":{"system":"sec-edgar","filing":"0001209191-20-028268","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120028268/doc4.xml","form_type":"4"}},{"id":3154176,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2020-05-11T20:25:07.000Z","date":"2020-05-07","kind":"exercise","acquired":true,"shares":2946,"price":6.54,"value":19266.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":7595,"source":{"system":"sec-edgar","filing":"0001209191-20-028268","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120028268/doc4.xml","form_type":"4"}},{"id":3154175,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2020-05-11T20:25:07.000Z","date":"2020-05-07","kind":"sale","acquired":false,"shares":6714,"price":19.6168,"value":131707.1952,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $19.37 to $20.00, inclusive.  The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 996 shares acquired under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan."}],"balance_after":4649,"source":{"system":"sec-edgar","filing":"0001209191-20-028268","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120028268/doc4.xml","form_type":"4"}},{"id":3226650,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2020-03-05T01:33:32.000Z","date":"2020-03-02","kind":"exercise","acquired":false,"shares":26500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on January 20, 2018, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":76500,"derivative":{"exercise_price":10.39,"expiration_date":"2027-01-19","underlying":"Common Stock","underlying_shares":26500},"source":{"system":"sec-edgar","filing":"0001209191-20-016416","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120016416/doc4.xml","form_type":"4"}},{"id":3226649,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2020-03-05T01:33:32.000Z","date":"2020-03-02","kind":"sale","acquired":false,"shares":9000,"price":24.0032,"value":216028.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.04, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":10367,"source":{"system":"sec-edgar","filing":"0001209191-20-016416","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120016416/doc4.xml","form_type":"4"}},{"id":3226648,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2020-03-05T01:33:32.000Z","date":"2020-03-02","kind":"sale","acquired":false,"shares":10000,"price":28,"value":280000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":19367,"source":{"system":"sec-edgar","filing":"0001209191-20-016416","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120016416/doc4.xml","form_type":"4"}},{"id":3226647,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2020-03-05T01:33:32.000Z","date":"2020-03-02","kind":"sale","acquired":false,"shares":7500,"price":23.5,"value":176250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":29367,"source":{"system":"sec-edgar","filing":"0001209191-20-016416","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120016416/doc4.xml","form_type":"4"}},{"id":3226646,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2020-03-05T01:33:32.000Z","date":"2020-03-02","kind":"exercise","acquired":true,"shares":26500,"price":10.39,"value":275335.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":36867,"source":{"system":"sec-edgar","filing":"0001209191-20-016416","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120016416/doc4.xml","form_type":"4"}},{"id":3255872,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2020-02-21T22:55:34.000Z","date":"2020-02-19","kind":"sale","acquired":false,"shares":2961,"price":16.4819,"value":48802.9059,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 19, 2020 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees."}],"balance_after":10367,"source":{"system":"sec-edgar","filing":"0001209191-20-011692","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120011692/doc4.xml","form_type":"4"}},{"id":3262236,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Restricted Stock Units","published_at":"2020-02-19T23:06:55.000Z","date":"2020-02-15","kind":"exercise","acquired":false,"shares":9675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 15, 2019, the reporting person was granted 38,700 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.  25% of the restricted stock units vested on February 15, 2020.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any an event within 30 days of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 15, 2019, the reporting person was granted 38,700 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.  25% of the restricted stock units vested on February 15, 2020.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any an event within 30 days of such date."}],"balance_after":29025,"derivative":{"underlying":"Common Stock","underlying_shares":9675},"source":{"system":"sec-edgar","filing":"0001209191-20-010750","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120010750/doc4.xml","form_type":"4"}},{"id":3262235,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2020-02-19T23:06:55.000Z","date":"2020-02-15","kind":"exercise","acquired":true,"shares":9675,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis."}],"balance_after":13328,"source":{"system":"sec-edgar","filing":"0001209191-20-010750","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120010750/doc4.xml","form_type":"4"}},{"id":3284076,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Restricted Stock Units","published_at":"2020-02-07T21:17:27.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":30300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Karyopharm Therapeutics Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 5, 2021, the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following each vesting date, but in any event within 30 days of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 5, 2021, the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following each vesting date, but in any event within 30 days of such date."}],"balance_after":30300,"derivative":{"underlying":"Common Stock","underlying_shares":30300},"source":{"system":"sec-edgar","filing":"0001209191-20-007502","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120007502/doc4.xml","form_type":"4"}},{"id":3284075,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-07T21:17:27.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":81200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 5, 2020.  The shares underlying this option vest as to 25% of the shares on February 5, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":81200,"derivative":{"exercise_price":18,"expiration_date":"2030-02-04","underlying":"Common Stock","underlying_shares":81200},"source":{"system":"sec-edgar","filing":"0001209191-20-007502","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120007502/doc4.xml","form_type":"4"}},{"id":3328741,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2019-12-31T14:06:01.000Z","date":"2019-12-27","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on January 20, 2018, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":103000,"derivative":{"exercise_price":10.39,"expiration_date":"2027-01-19","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-062196","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919119062196/doc4.xml","form_type":"4"}},{"id":3328740,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2019-12-31T14:06:01.000Z","date":"2019-12-27","kind":"sale","acquired":false,"shares":5000,"price":20,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":3653,"source":{"system":"sec-edgar","filing":"0001209191-19-062196","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919119062196/doc4.xml","form_type":"4"}},{"id":3328739,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2019-12-31T14:06:01.000Z","date":"2019-12-27","kind":"exercise","acquired":true,"shares":5000,"price":10.39,"value":51950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":8653,"source":{"system":"sec-edgar","filing":"0001209191-19-062196","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919119062196/doc4.xml","form_type":"4"}},{"id":3346328,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2019-12-10T22:18:20.000Z","date":"2019-12-06","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on January 20, 2018, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":108000,"derivative":{"exercise_price":10.39,"expiration_date":"2027-01-19","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-059914","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919119059914/doc4.xml","form_type":"4"}},{"id":3346327,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2019-12-10T22:18:20.000Z","date":"2019-12-06","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on January 15, 2017, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":13000,"derivative":{"exercise_price":6.54,"expiration_date":"2026-01-14","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-059914","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919119059914/doc4.xml","form_type":"4"}},{"id":3346326,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2019-12-10T22:18:20.000Z","date":"2019-12-06","kind":"sale","acquired":false,"shares":3000,"price":17.456,"value":52368.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.345 to $17.685, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3653,"source":{"system":"sec-edgar","filing":"0001209191-19-059914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919119059914/doc4.xml","form_type":"4"}},{"id":3346325,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2019-12-10T22:18:20.000Z","date":"2019-12-06","kind":"sale","acquired":false,"shares":5000,"price":17.4512,"value":87256.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.35 to $17.62, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":6653,"source":{"system":"sec-edgar","filing":"0001209191-19-059914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919119059914/doc4.xml","form_type":"4"}},{"id":3346324,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2019-12-10T22:18:20.000Z","date":"2019-12-06","kind":"sale","acquired":false,"shares":5000,"price":17.4568,"value":87284.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.34 to $17.61, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":11653,"source":{"system":"sec-edgar","filing":"0001209191-19-059914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919119059914/doc4.xml","form_type":"4"}},{"id":3346323,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2019-12-10T22:18:20.000Z","date":"2019-12-06","kind":"exercise","acquired":true,"shares":5000,"price":10.39,"value":51950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":16653,"source":{"system":"sec-edgar","filing":"0001209191-19-059914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919119059914/doc4.xml","form_type":"4"}},{"id":3346322,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2019-12-10T22:18:20.000Z","date":"2019-12-06","kind":"exercise","acquired":true,"shares":5000,"price":6.54,"value":32700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,772 shares acquired under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan."}],"balance_after":11653,"source":{"system":"sec-edgar","filing":"0001209191-19-059914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919119059914/doc4.xml","form_type":"4"}},{"id":3649082,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Restricted Stock Units","published_at":"2019-02-19T21:29:20.000Z","date":"2019-02-15","kind":"grant","acquired":true,"shares":38700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Karyopharm Therapeutics Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 15, 2020, the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following each vesting date, but in any event within 30 days of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 15, 2020, the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following each vesting date, but in any event within 30 days of such date."}],"balance_after":38700,"derivative":{"underlying":"Common Stock","underlying_shares":38700},"source":{"system":"sec-edgar","filing":"0001209191-19-011084","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919119011084/doc4.xml","form_type":"4"}},{"id":3649081,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-19T21:29:20.000Z","date":"2019-02-15","kind":"grant","acquired":true,"shares":102800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 15, 2019.  The shares underlying this option vest as to 25% of the shares on February 15, 2020, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":102800,"derivative":{"exercise_price":9.21,"expiration_date":"2029-02-14","underlying":"Common Stock","underlying_shares":102800},"source":{"system":"sec-edgar","filing":"0001209191-19-011084","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919119011084/doc4.xml","form_type":"4"}},{"id":3819269,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2018-09-11T22:08:41.000Z","date":"2018-09-10","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on January 20, 2018, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":113000,"derivative":{"exercise_price":10.39,"expiration_date":"2027-01-19","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-050553","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919118050553/doc4.xml","form_type":"4"}},{"id":3819268,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2018-09-11T22:08:41.000Z","date":"2018-09-10","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on January 15, 2017, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":18000,"derivative":{"exercise_price":6.54,"expiration_date":"2026-01-14","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-050553","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919118050553/doc4.xml","form_type":"4"}},{"id":3819267,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2018-09-11T22:08:41.000Z","date":"2018-09-10","kind":"sale","acquired":false,"shares":10000,"price":18.9046,"value":189046.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.27 to $19.08, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2881,"source":{"system":"sec-edgar","filing":"0001209191-18-050553","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919118050553/doc4.xml","form_type":"4"}},{"id":3819266,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2018-09-11T22:08:41.000Z","date":"2018-09-10","kind":"exercise","acquired":true,"shares":5000,"price":10.39,"value":51950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":12881,"source":{"system":"sec-edgar","filing":"0001209191-18-050553","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919118050553/doc4.xml","form_type":"4"}},{"id":3819265,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2018-09-11T22:08:41.000Z","date":"2018-09-10","kind":"exercise","acquired":true,"shares":5000,"price":6.54,"value":32700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":7881,"source":{"system":"sec-edgar","filing":"0001209191-18-050553","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919118050553/doc4.xml","form_type":"4"}},{"id":3938449,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2018-05-10T20:10:07.000Z","date":"2018-05-10","kind":"sale","acquired":false,"shares":2000,"price":18.012,"value":36024.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in transactions at $18.00 and $18.06. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price."}],"balance_after":2881,"source":{"system":"sec-edgar","filing":"0001209191-18-029243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919118029243/doc4.xml","form_type":"4"}},{"id":4010064,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2018-03-06T21:54:05.000Z","date":"2018-03-05","kind":"sale","acquired":false,"shares":2500,"price":16.0304,"value":40076.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $16.00 to $16.06, inclusive.  The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price."}],"balance_after":4881,"source":{"system":"sec-edgar","filing":"0001209191-18-017330","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919118017330/doc4.xml","form_type":"4"}},{"id":4046890,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2018-02-20T21:21:56.000Z","date":"2018-02-16","kind":"sale","acquired":false,"shares":1486,"price":15.0054,"value":22298.0244,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. These shares were sold in transactions at $15.00 and $15.08. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price."}],"balance_after":7381,"source":{"system":"sec-edgar","filing":"0001209191-18-011324","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919118011324/doc4.xml","form_type":"4"}},{"id":4046889,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2018-02-20T21:21:56.000Z","date":"2018-02-15","kind":"sale","acquired":false,"shares":1014,"price":15.0187,"value":15228.9618,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $15.00 to $15.04, inclusive.  The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price."}],"balance_after":8867,"source":{"system":"sec-edgar","filing":"0001209191-18-011324","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919118011324/doc4.xml","form_type":"4"}},{"id":4070054,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Common Stock","published_at":"2018-02-08T21:10:05.000Z","date":"2018-02-07","kind":"sale","acquired":false,"shares":1500,"price":13,"value":19500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":9881,"source":{"system":"sec-edgar","filing":"0001209191-18-008420","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919118008420/doc4.xml","form_type":"4"}},{"id":4089511,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO, GC & Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-25T21:29:59.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 24, 2018.  The shares underlying this option vest as to 25% of the shares on January 24, 2019, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":125000,"derivative":{"exercise_price":10.45,"expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-18-005380","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919118005380/doc4.xml","form_type":"4"}},{"id":4132976,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, OPS, BUS DEV, GC & SEC"}}],"security":"Stock Option (right to buy)","published_at":"2017-12-13T21:04:01.000Z","date":"2017-12-12","kind":"exercise","acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on January 15, 2017, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":23000,"derivative":{"exercise_price":6.54,"expiration_date":"2026-01-16","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-17-065406","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919117065406/doc4.xml","form_type":"4"}},{"id":4132975,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, OPS, BUS DEV, GC & SEC"}}],"security":"Common Stock","published_at":"2017-12-13T21:04:01.000Z","date":"2017-12-12","kind":"sale","acquired":false,"shares":644,"price":9.5853,"value":6172.9332,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at $9.56 and $9.59. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":11381,"source":{"system":"sec-edgar","filing":"0001209191-17-065406","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919117065406/doc4.xml","form_type":"4"}},{"id":4132974,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, OPS, BUS DEV, GC & SEC"}}],"security":"Common Stock","published_at":"2017-12-13T21:04:01.000Z","date":"2017-12-12","kind":"sale","acquired":false,"shares":16356,"price":9.9317,"value":162442.8852,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.60 to $10.59, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":12025,"source":{"system":"sec-edgar","filing":"0001209191-17-065406","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919117065406/doc4.xml","form_type":"4"}},{"id":4132973,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, OPS, BUS DEV, GC & SEC"}}],"security":"Common Stock","published_at":"2017-12-13T21:04:01.000Z","date":"2017-12-12","kind":"exercise","acquired":true,"shares":17000,"price":6.54,"value":111180.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":28381,"source":{"system":"sec-edgar","filing":"0001209191-17-065406","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919117065406/doc4.xml","form_type":"4"}},{"id":4132972,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, OPS, BUS DEV, GC & SEC"}}],"security":"Common Stock","published_at":"2017-12-13T21:04:01.000Z","date":"2017-12-11","kind":"sale","acquired":false,"shares":10042,"price":10.8799,"value":109255.9558,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $10.68 to $11.15, inclusive.  The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":11381,"source":{"system":"sec-edgar","filing":"0001209191-17-065406","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919117065406/doc4.xml","form_type":"4"}},{"id":4167248,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, OPS, BUS DEV, GC & SEC"}}],"security":"Common Stock","published_at":"2017-11-09T21:03:18.000Z","date":"2017-11-07","kind":"sale","acquired":false,"shares":4958,"price":11.2455,"value":55755.189,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 6, 2017 and November 7, 2017 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees."}],"balance_after":21423,"source":{"system":"sec-edgar","filing":"0001209191-17-059944","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919117059944/doc4.xml","form_type":"4"}},{"id":4171128,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, OPS, BUS DEV, GC & SEC"}}],"security":"Restricted Stock Units","published_at":"2017-11-06T21:05:23.000Z","date":"2017-11-05","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Karyopharm Therapeutics Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On November 5, 2015, the reporting person was granted 30,000 restricted stock units.  50% of the restricted stock units vested on November 5, 2016.  The remaining 50% of the restricted stock units vested on November 5, 2017.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On November 5, 2015, the reporting person was granted 30,000 restricted stock units.  50% of the restricted stock units vested on November 5, 2016.  The remaining 50% of the restricted stock units vested on November 5, 2017.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-17-059396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919117059396/doc4.xml","form_type":"4"}},{"id":4171127,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, OPS, BUS DEV, GC & SEC"}}],"security":"Common Stock","published_at":"2017-11-06T21:05:23.000Z","date":"2017-11-05","kind":"exercise","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Karyopharm Therapeutics Inc. common stock."}],"balance_after":26381,"source":{"system":"sec-edgar","filing":"0001209191-17-059396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919117059396/doc4.xml","form_type":"4"}},{"id":4191764,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, OPS, BUS DEV, GC & SEC"}}],"security":"Common Stock","published_at":"2017-10-04T20:06:38.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":1500,"price":12,"value":18000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":11381,"source":{"system":"sec-edgar","filing":"0001209191-17-055750","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919117055750/doc4.xml","form_type":"4"}},{"id":4206909,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, OPS, BUS DEV, GC & SEC"}}],"security":"Common Stock","published_at":"2017-09-18T20:09:12.000Z","date":"2017-09-15","kind":"sale","acquired":false,"shares":2000,"price":11,"value":22000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":12881,"source":{"system":"sec-edgar","filing":"0001209191-17-053148","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919117053148/doc4.xml","form_type":"4"}},{"id":4219556,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, OPS, BUS DEV, GC & SEC"}}],"security":"Common Stock","published_at":"2017-09-01T21:43:26.000Z","date":"2017-06-26","kind":"sale","acquired":false,"shares":805,"price":10.0261,"value":8071.0105,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price.  These shares were sold in transactions at $10.00 and $10.07.  The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Amount also reflects the number of shares sold by the reporting person as previously reported on the Form 4 filed on August 30, 2017 (the \"Previous Form 4\") as well as the acquisition of 2,062 shares under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan, which was previously disclosed on the Previous Form 4."}],"balance_after":14881,"source":{"system":"sec-edgar","filing":"0001209191-17-051076","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919117051076/doc4.xml","form_type":"4"}},{"id":4221361,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, OPS, BUS DEV, GC & SEC"}}],"security":"Common Stock","published_at":"2017-08-30T20:09:36.000Z","date":"2017-08-29","kind":"sale","acquired":false,"shares":2195,"price":10,"value":21950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,062 shares acquired under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan."}],"balance_after":15686,"source":{"system":"sec-edgar","filing":"0001209191-17-050698","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919117050698/doc4.xml","form_type":"4"}},{"id":4482775,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, OPS, BUS DEV, GC & SEC"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-24T22:38:23.000Z","date":"2017-01-20","kind":"grant","acquired":true,"shares":118000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 20, 2017.  The shares underlying this option vest as to 25% of the shares on January 20, 2018, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":118000,"derivative":{"exercise_price":10.39,"expiration_date":"2027-01-19","underlying":"Common Stock","underlying_shares":118000},"source":{"system":"sec-edgar","filing":"0001209191-17-005326","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919117005326/doc4.xml","form_type":"4"}},{"id":4557253,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,CORP DEV,GEN COUNSEL&SEC."}}],"security":"Common Stock","published_at":"2016-11-14T22:48:36.000Z","date":"2016-11-09","kind":"sale","acquired":false,"shares":4342,"price":8.1862,"value":35544.4804,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 8, 2016 and November 9, 2016 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees."}],"balance_after":15819,"source":{"system":"sec-edgar","filing":"0001209191-16-149846","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919116149846/doc4.xml","form_type":"4"}},{"id":4563533,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,CORP DEV,GEN COUNSEL&SEC."}}],"security":"Restricted Stock Units","published_at":"2016-11-08T21:09:37.000Z","date":"2016-11-05","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Karyopharm Therapeutics Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On November 5, 2015, the reporting person was granted 30,000 restricted stock units. 50% of the restricted stock units vested on November 5, 2016, and the remaining 50% of the restricted stock units will vest on November 5, 2017.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On November 5, 2015, the reporting person was granted 30,000 restricted stock units. 50% of the restricted stock units vested on November 5, 2016, and the remaining 50% of the restricted stock units will vest on November 5, 2017.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."}],"balance_after":15000,"derivative":{"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-16-148843","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919116148843/doc4.xml","form_type":"4"}},{"id":4563532,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":134094,"kind":"person","name":"Primiano Christopher Brett","position":1,"cik":"0001603510","reported_name":"Primiano Christopher Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,CORP DEV,GEN COUNSEL&SEC."}}],"security":"Common Stock","published_at":"2016-11-08T21:09:37.000Z","date":"2016-11-05","kind":"exercise","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Karyopharm Therapeutics Inc. common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,161 shares acquired under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan."}],"balance_after":20161,"source":{"system":"sec-edgar","filing":"0001209191-16-148843","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919116148843/doc4.xml","form_type":"4"}}]}